We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| African Pioneer Plc | ASP | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 3.75 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 3.75 | 3.75 |
| Top Posts |
|---|
Posted at 15/12/2008 16:56 by ltinvestor Ecoanimal health EAH good divi and capital growth potential dyor |
Posted at 30/5/2008 00:00 by backmarker there was a reasonably positive article on ASP in SHARES mag. today.probably that which helped lift the share price |
Posted at 21/3/2007 11:39 by via con BTW ASP´s CEO is on CNBCEdit. FWIW , he was very good , composed, upbeat, and confident. |
Posted at 06/2/2007 13:26 by gac100 Mark Woodbridge has now resigned from the ASP Board:Ascribe plc 06 February 2007 Press Release 06 February 2007 Ascribe plc ('Ascribe' or the 'Company') Directorate Mark Woodbridge, a non-executive director of Ascribe, has informed the Company that in view of recent press comment he considers it to be in the best interests of the Company for him to leave the Board. Accordingly he has, today, tendered his resignation. The Board of Ascribe would like to thank Mark for his valuable contribution since his appointment in May 2005. |
Posted at 06/2/2007 10:44 by gac100 As I say all is probably well at ASP. The bottom line for me is that I'm personally uncomfortable holding a company where a serving director and an ex-director are under investigation by the Serious Fraud Office. Mark Woodbridge I see has just stepped down from the Board of AT Communications.RNS Number:7771Q AT Communications Group Plc 06 February 2007 6 February 2007 AT Communications Group Plc Board Change AT Communications Group plc (AIM: ATCG, "ATC"), the business-to-business communications group, announces that Mark Woodbridge, Finance Director, has stepped down from the Board. I should add: "ATC has already started the recruitment process for a new Finance Director as the Board and Mark Woodbridge had planned for him to step down before the second anniversary of ATC's listing." |
Posted at 03/2/2007 12:55 by gac100 Probably nothing in it, and nothing to worry about for Ascribe investors, but I've sold my holding, being uncomfortable with the following:"the FT established that the three houses in Oxfordshire and Warwickshire searched by the SFO belonged to Chris Moore, who stepped aside as Torex Retail chairman on Wednesday, Rob Loosemore, the company's former executive chairman, and Mark Woodbridge, a close associate of Mr Moore." Chris Moore and Mark Woodbridge were appointed non-executive directors of Ascribe in May 2005. Moore resigned in Dec 2005. His resignation was announced in Oct; Ascribe implied that he had a lot on his plate with Torex "recently appointed executive chairman of Torex Retail plc", although he would "remain a strategic consultant to [Ascribe]." Moore sold his 10,822,771 Ascribe shares in Feb 2006 "in response to institutional investor demand" (Artemis increased its stake in Ascribe at the same time). Woodbridge, as far as I know, is still a non-executive director of Ascribe and was chairman of the company's Audit Committee for the year ending 6 Jun 2006 (Annual Report). On the same day that Moore and Woodbridge were appointed to the Ascribe Board (in May 2005), the company was "pleased to announce both the appointment of Evolution Securities Limited as their new nominated adviser, broker and financial adviser and Citigate Dewe Rogerson as their financial public relations adviser with immediate affect." Evolution and Citigate also represent Torex. (although Ascribe later Aug 2006 appointed Cenkos Securities its nominated adviser and broker). On the same day Moore's intention to resign as non-executive director of Ascribe was announced (in Oct 2005), the company appointed Graham Lewis as Chief Executive. Lewis lasted less than a year. Lewis's intention to resign was announced at the end of Jun 2006 and he resigned at the end of July, 6 weeks before Ascribe announced its final results for the year ended 30 Jun. His resignation was "Due to personal circumstances" and passed with very little ceremony (the announcement was made in an "Acquisition" RNS). Ascribe has made a good number of acquisitions over the past couple of years. There is speculation that Torex's problems may be connected with how the company dealt with acquisitions and contracts in its books (cf. ISoft). Moore and /or Woodbridge non-exec directors with Ascribe remember probably had no input at all into how Ascribe did its accounts, but I have no way of knowing. Finally, as already mentioned Artemis is a major institutional shareholder in Ascribe, and was buying when Moore was selling. It was been alleged that Artemis sold its entire holding in Torex before the sh*t hit the fan there. Artemis's stake in Ascribe was a very marginal factor in my decision, and is probably of more interest to Torex investors than Ascribe investors. I repeat there may well be nothing to worry about for ASP investors. I'm very, very cautious by nature. |
Posted at 30/1/2007 11:08 by v6syncro gac100I tend to agree with you about ASP "playing fair". I suspect that it is the Trust that might not be! I will back when I have further info. Thanks for the link. |
Posted at 29/1/2007 14:29 by gac100 V6SyncroThis is all I can find: "Mid Cheshire Hospitals NHS Trust Board of Directors Minutes of the Meeting held at 9.30am on Monday 27 November 2006 In the Memorial Hall, Northwich" From the minutes (page 6) "Pharmacy System: Business case for a replacement Mrs Donald presented the paper. She stressed that funding was available from within her budget. Ascribe was used extensively elsewhere, and would link with the Trusts own paper administration system. The project was well scoped. After discussion it was resolved to approve the procurement of the ascribe pharmacy system as replacement existing system." This is 6 weeks before the ASP 10 Jan Trading Statement, which stated : "...Ascribe's Pharmacy Division has won several new health IT contracts in the first half-year. These include the sale of Ascribe's Pharmacy Department and Electronic Prescribing solutions to: ... Mid-Cheshire Hospitals NHS Trust" Looks to me like ASP are "playing fair" |
Posted at 21/9/2006 15:47 by tiltonboy CURRY,That is the same number of shares they previously held, but after the issue of new shares by ASP, their % holding has fallen below 11%. tiltonboy |
Posted at 12/9/2006 07:56 by currypasty RNS Number:8016IAscribe plc 12 September 2006 Press Release 12 September 2006 Ascribe plc ("Ascribe" or "the Group") Preliminary Results Bolton, UK: Ascribe (AIM:ASP), the health IT Group, today announces its Preliminary Results for the year ended 30 June 2006. Highlights - Revenues up 85% to #9.9m (2005: #5.3m) - Successful completion and integration of three significant acquisitions - Like for like revenues up 15% - Recurring maintenance revenue at 62% (2005: 61%) - Earnings before interest, taxation, depreciation and amortisation(1) (EBITDA) increased 111% to #2.3m (2005: #1.1m) - Adjusted operating profit(2) up 141% to #2.2m (2005: #0.9m) - Operating margin(2) of 22% (2005: 17%) - Adjusted profit before tax(2) up 129% to #2.2m - Profit before tax up by 111% to #1.4m (2005: #0.7m) - Operating cash is 112% of operating profit - Adjusted earnings per share(2) up 86% to 1.73p (2005: 0.93p) - Dividend of 0.13p per share proposed - an increase of 30% on last year |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
